Replies to post #3561 on Nexien BioPharma Inc (NXEN)

[ChuckBits]

This part of patent news sounds good:

Based on the current patient population, it is anticipated that the annual market to treat patients with DM Type 1 and DM Type 2 could range between $500 million to $1 billion.